A study reports sustained improvement in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension following CD19 CAR T-cell therapy over one year. This research highlights the potential of CAR T-cell therapy in treating complex rare diseases.
sustained improvement of systemic lupus erythematosus associated pulmonary arterial hypertension by cd19 car t cell therapy 1 year haemodynamic follow up
Original title: “Sustained improvement of systemic lupus erythematosus‑associated pulmonary arterial hypertension by CD19 CAR T-cell therapy: 1‑year haemodynamic follow‑up.”